Page 17 - MemoriaESP-Eng
P. 17
www.ciberesp.es
Epidemiology and Prevention of Chronic Diseases
Programme The research programme in epidemiology and prevention of chronic diseases arises
from the recognition that the risk and prognostic factors of primary diseases and
description
other chronic health problems are, to a large extent, common.
The creation of this area also derives from the interest to optimize the research de-
signs and resources, since one and the same study can generate information about
the determinants of different diseases simultaneously.
The scientific knowledge generated in this area is useful to provide guidance both
for clinical and public health strategies, to reduce the incidence of these diseases
and to improve their prognosis, to control exposure to risk factors and to prevent
initial exposure to said factor (primary prevention).
The large variety of factors determining these chronic health problems and the wide
range of approaches necessary for studying them mean that collaborative research
must be organized with other areas of the CIBER through transverse research ac-
tions, regardless of whether said actions are genetic research, population interven-
tions or the development of new data analysis methods.
The main lines of research included in this programme are the following:
• Environmental and genetic determinants of cancer.
• Natural history of cardiovascular disease.
• Result reporting and transfer information systems.
• Eating behaviors and their effects on health.
• Epidemiology and prevention of traffic injuries.
• Other chronic disorders with a high social impact (environmental and genetic
determinants of respiratory diseases and reproductive disorders).
13
20
T
OR
P
RE
L
The strategic objectives of the programme are:
A
Objectives
NU
N
A
• To generate scientific knowledge of direct relevance for controlling chronic P /
S
diseases which are the main causes of loss of health and the use of healthcare RE
services in Spain.
E
IB
• To transfer this knowledge to clinical practice and to public health.
C
17